Milk-Free Probiotic Acidophilus plus FOS by Bluebonnet — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size

Other Combinations Product Type

25% Evidence Coverage

Supplement Facts — Evidence Check

L. acidophilus

L. bulgaricus

Bifidobacterium Bifidum

FOS

100 mg

📊 Market median: 100.0mg (1 products) 📚 42 studies (Tier A: 1, B: 15)

This product: 100mg

Other Ingredients

Kosher Vegetable Capsules Vegetable Cellulose Vegetable Magnesium Stearate

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (99% of products) Structure/Function (91% of products) Nutrient (14% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one capsule daily or as directed by a healthcare practitioner.

🧪 Formulation Notes

Bluebonnet’s Milk-Free Probiotic Acidophilus plus FOS Capsules contain over three billion viable microorganisms per capsule. Specially formulated with lactobacillus acidophilus, lactobacillus bulgaricus, bifidobacterium bifidum and FOS (fructooligosaccharides). FOS is a unique carbohydrate from chicory root extract. Designed to help promote the growth of friendly bacteria in the gastrointestinal tract.

Made with non GMO ingredients

L. Acidophilus, L. Bulgaricus, Bifidum

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans. Also free of yeast, gluten, barley, rice and sodium.

Additional Information

Made with non GMO ingredients

Gluten free

Refrigeration required.

Product Details

UPC / SKU 7 43715 00912 7

DSLD Entry Date 2019-07-24

Product Type Other Combinations

Form Capsule

Brand Bluebonnet

DSLD ID 204362

Data Updated 2026-04-11

Research Evidence

691 Research Sources

52 Avg Quality Score

255 Clinical Trial

205 Meta Analysis

123 Rct

81 Systematic Review

18 Cochrane Review

2 Guideline

2 Regulatory Source

1 Other

1 Narrative Review

1 Openfda Safety

A Probiotics for preventing acute upper respiratory tract infections

Systematic Review The Cochrane database of systematic reviews 2022

PubMed DOI Cochrane

A Probiotics for preventing acute upper respiratory tract infections

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

A Probiotics for maintenance of remission in ulcerative colitis

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Probiotics for induction of remission in ulcerative colitis

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Probiotics for preventing acute upper respiratory tract infections

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Probiotics for treating eczema

Meta Analysis The Cochrane database of systematic reviews 2018

PubMed DOI Cochrane

A Probiotics for treating acute infectious diarrhoea

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies

Systematic Review International journal of molecular sciences 2022

PubMed DOI

A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI

A Probiotics to prevent infantile colic

Meta Analysis The Cochrane database of systematic reviews 2019

PubMed DOI

View all evidence for Probiotics →